Puberty blockers cause infertility, sexual dysfunction and brain damage

Bone density reduction during blocker use is real, monitored, and in the clinical literature, and that one accurate detail lends the whole list an authority it has not earned. Infertility risk is a genuine consideration, but it arises if someone proceeds to hormones without banking gametes first, not from blockers alone, and good care addresses that conversation early. Brain developmental risk is not an established finding in the clinical literature on GnRH analogues used this way: what exists are animal studies and theoretical concerns, which is a very different thing from demonstrated harm in human patients. Presenting all four items as though they carry the same evidential weight gives families a picture of certain, stacked dangers that does not reflect what the evidence actually shows, and families who make decisions on that picture may be withholding a treatment that could spare their child years of distress and more significant interventions later.